AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
blog
Here’s one promising approach to address rural veterinary shortages
There are veterinarians who want to work in rural areas of America but are unable to do so—for financial reasons. The great news is that legislation…
AVMA news
AVMA leaders to discuss environmental sustainability, spectrum of care
Meeting this July in Denver, the AVMA House of Delegates (HOD) will consider new and revised policy proposals dealing with wolf hybrids, tail docking,…
AVMA news
A research facility ahead of its time
The state-of-the-art National Bio and Agro-Defense Facility, based in the nation’s heartland, is arguably the most advanced animal agriculture…